Frequently Asked Qustions
The COVID-19 pandemic has caused supply chain disruptions and hampered the expansion of the healthcare industry, thus limiting the market expansion.
North America accounted for the most heightened share in the global cell culture monitoring biosensor market.
The primary factors driving the growth of the market for these devices are the rising incidence of cancer and the increased use of cell culture monitoring biosensors.
The electrochemical biosensors segment had a major share in the global market in 2022.
The pharmaceutical industry segment had a major share in the global market.